Clinical Trial Update: The Role of Transdermal CO2 in MDA Level in Patient Underwent Abdominal Aortic Temporary Cross Clamp [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating transdermal CO2 effects on MDA levels in patients with placenta accreta undergoing abdominal aortic temporary cross-clamp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Placenta Accreta

Drugs mentioned

• Transdermal CO2

Snippet

Sponsor: Universitas Airlangga | Conditions: Placenta Accreta | Phase 4 | Status: UNKNOWN